Efficacy and Safety of KAI-9531 in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

A Research Study to See How a New Medicine (NNC0487-0111) Works in People With Overweight or Obesity When Injected Under the Skin

NCT06064006 ·Status: COMPLETED ·Phase: PHASE2

A Study of TG103 Injection in Non-diabetic Overweight or Obesity

NCT05997576 ·Status: COMPLETED ·Phase: PHASE3

Effect and Safety of Liraglutide 3.0 mg in Subjects With Overweight or Obesity and Type 2 Diabetes Mellitus Treated With Basal Insulin

NCT02963922 ·Status: COMPLETED ·Phase: PHASE3

The Efficacy and Safety of Liraglutide on Body Weight Loss in Obese and Overweight Patients

NCT04605861 ·Status: COMPLETED ·Phase: PHASE3

A Study of ZT002 Injection With Subjects With Overweight or Obesity

NCT07020884 ·Status: COMPLETED ·Phase: PHASE2

A Research Study on How NNC0638-0355, a New Medicine, Works in People Living With Overweight or Obesity

NCT06577766 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Effect of 2-year Administration of CP-945,598 on Weight Loss Efficacy and Safety.

NCT00396448 ·Status: TERMINATED ·Phase: PHASE3

A Study Evaluating the Effect of Daily Oral RO7795081 in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity

NCT07081958 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Phase III Clinical Study Comparing the Efficacy and Safety of GZR18 Injection and Semaglutide (Wegovy®) in Adult Obese or Overweight Subjects

NCT07150975 ·Status: RECRUITING ·Phase: PHASE3

A Long-Term Study To Examine The Effects Of CP-945,598 On Weight Loss And Safety

NCT00375401 ·Status: TERMINATED ·Phase: PHASE3

Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity.

NCT03856047 ·Status: COMPLETED ·Phase: PHASE2

A Research Study Looking at Different Oral Formulations and the Effect of Food Intake on How the Medicine NNC0487-0111 Behaves in the Body of Participants Living With Overweight or Obesity

NCT06478563 ·Status: COMPLETED ·Phase: PHASE1

A Research Study on How NNC0487-0111, a New Medicine, Works in Chinese Participants When Injected Under the Skin.

NCT07121153 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Semaglutide Ingection in Subjects With Type 2 Diabetes

NCT05950516 ·Status: UNKNOWN ·Phase: PHASE3

Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes Mellitus

NCT02453711 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Liraglutide on Body Weight in Obese Subjects or Overweight Subjects With Co-morbidities

NCT04487743 ·Status: UNKNOWN ·Phase: PHASE3

A Study of HS-20094 in Chinese Adults with Overweight or Obesity

NCT06839664 ·Status: RECRUITING ·Phase: PHASE3

A Study of TG103 Injection in the Management of Non-diabetic Overweight or Obesity

NCT06226090 ·Status: COMPLETED ·Phase: PHASE2

A Research Study Investigating NNC0247-0829 for Weight Management in People With Overweight or Obesity

NCT04010786 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of HRS9531 Injections in Overweight or Obese Subjects

NCT06054698 ·Status: COMPLETED ·Phase: PHASE2

A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or Overweight

NCT06124807 ·Status: COMPLETED ·Phase: PHASE2

An Investigational Drug Study in Obese (Considerably Overweight) Patients (0364-006)

NCT00109148 ·Status: COMPLETED ·Phase: PHASE2

A 1-Year Study On The Effects Of CP-945,598 For The Treatment Of Obesity In Overweight Type 2 Diabetic Patients

NCT00391196 ·Status: TERMINATED ·Phase: PHASE3

Research Study of a New Medicine (NNC9204-1706) in People With Overweight or Obesity

NCT03661879 ·Status: COMPLETED ·Phase: PHASE1

Investigate Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-0530 Alone and in Combination With Liraglutide in Overweight to Obese But Otherwise Healthy Male Subjects

NCT02235961 ·Status: COMPLETED ·Phase: PHASE1